Acadia Healthcare Reports Significant Q4 Loss, Lower 2026 Profit Guidance Amid Impairment Charge

summarizeSummary

Acadia Healthcare announced a significant net loss for Q4 and full year 2025 due to a nearly $1 billion goodwill impairment, alongside lower adjusted profitability and reduced financial guidance for 2026.

check_boxKey Events

• Significant Q4 Net Loss Driven by Goodwill Impairment

  The company reported a net loss of $(13.02) per diluted share for Q4 2025, primarily due to a $996.2 million non-cash goodwill impairment charge. Adjusted diluted EPS for the quarter was $0.07, down from $0.64 in the prior-year period.

• Lower Full Year 2025 Adjusted Profitability

  Full year 2025 adjusted net income attributable to Acadia was $2.00 per diluted share, a decrease from $3.30 in 2024. Adjusted EBITDA for the year was $608.9 million, down from $709.0 million in the prior year.

• Reduced Full Year 2026 Financial Guidance

  Acadia provided 2026 guidance with Adjusted EBITDA projected between $575 million and $610 million, and Adjusted earnings per diluted share between $1.30 and $1.55, both lower than 2025 actuals.

• Operational Headwinds and Legal Costs Impact Results

  Q4 2025 results included a $52.7 million adjustment to professional and general liability reserves and $147 million in legal settlements expense. The 2026 guidance anticipates a $25-$30 million negative impact on Adjusted EBITDA from New York Medicaid policy changes.

auto_awesomeAnalysis

Acadia Healthcare reported a substantial net loss for Q4 and full year 2025, primarily driven by a $996.2 million non-cash goodwill impairment charge and increased legal settlement expenses. The company's adjusted profitability also declined significantly in 2025. Furthermore, the full year 2026 financial guidance for Adjusted EBITDA and Adjusted EPS is notably lower than 2025 results, indicating a challenging outlook. These financial headwinds, including impacts from New York Medicaid policy changes and higher professional and general liability reserves, underscore the operational challenges facing the company under its recently appointed CEO, Debbie Osteen, who emphasized steady leadership and operational discipline.